Cerebral Oxygen Saturation Monitoring During Optimum Cord Management in Preterm Infants (COSMIC)

Imperial College Healthcare NHS Trust

Status: Enrolling

Conditions: Pre-Term

Treatments: Other: Cerebral NIRS monitoring at delivery

Study type: Observational

Funder types: Other

Identifiers

NCT06526091

22QC7933

Details and patient eligibility

About

This study will assess the feasibilty measuring cerebral oxygen saturations using a Near Infrared Spectroscopy (NIRS) monitor immediately after delivery of preterm infants. The investigators aim to evaluate the effects of optimum cord management on cerebral oxygenation in this cohort

Full description

Optimal cord management is defined by delaying clamping of the umbilical cord for 1 minute after delivery and is recommend in all neonates, regardless of gestational age. Transfusion of blood from placenta to baby in this minute enables smooth cardiovascular transition and stable cerebral perfusion. Preterm infants are at increased risk of haemodynamic instability and brain injury if the cord is clamped too early. It remains unclear what the optimum time is to clamp the cord in preterm infants, and it is likely different for each baby. Current monitoring of heart rate and peripheral oxygen saturations does not correlate well with oxygen delivery to the brain. Near infrared spectroscopy (NIRS) is a non-invasive method of measuring regional cerebral oxygenation saturations. NIRS may be a helpful monitoring tool to guide optimum timing of cord clamping in preterm infants.

This study aims to assess the feasibility of using the INVOS 5100 NIRS monitor immediately after delivery in preterm infants born before 34 weeks gestational age. The investigators aim to assess if they can generate meaningful data on brain oxygen levels in the first few minutes of life. The secondary objectives are to use this data to describe the changes in heart rate, peripheral oxygen and cerebral oxygen saturations during placental transfusion and cord clamping.

The investigators will use the INVOS device to measure cerebral oxygenation immediately after delivery, during placental transfusion and cord clamping. We will assess the feasibility of the INVOS device for this purpose. We will use the INVOS data and routinely collected data at delivery to evaluate the effect of optimum cord management on cerebral perfusion, heart rate and peripheral oxygen saturations.

Enrollment: 40 estimated patients

Sex: All

Ages: 1 minute to 24 hours old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All babies eligible for optimum cord management born before 34 completed weeks gestational age
• Parental consent

Exclusion criteria

• Multiple pregnancies
• Infants for whom resuscitation at birth is not appropriate
• Antenatal or immediate postnatal diagnosis of severe congenital anomaly
• Infants with complex congenital cardiac disease

Trial design

40 participants in 1 patient group

Preterm infants

Description:

Preterm infants born at less than 34 completed weeks gestation

Treatment:

Other: Cerebral NIRS monitoring at delivery